AstraZeneca admits its Covishield vaccine may lead to rare side effect
Pharmaceutical giant AstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition. , according to court documents
Warning: Editorial use only. Contact your sales representative for all commercial (including advertorial) and promotional uses.